Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,443 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Completed

Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00114166

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
View all 78 locations
View Trial Details
Completed

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00459290

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Kaiser Permanente Medical Center - Los Angeles Los Angeles, California, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States
View all 22 locations
View Trial Details
Completed

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

NCT00569673

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
View all 37 locations
View Trial Details
Completed

CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer

NCT01652079

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

NCT02948075

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Federal State budget Scientific Agency "Russian Oncological Research Center n.a. N.N. Blokhin" Moscow, Russia
  • Medical Radiological Scientific Center n.a. A.F. Tsyb - branch of Federal State Budget Agency "Public Medical Scientific Radiology Center" of Ministry of Health of Russian Federation Obninsk, Russia
  • State Budget Agency of Stavropol Territory Healthcare Pyatigorsk Oncologic Dispensary Pyatigorsk, Russia
  • State Budget Agency of Healthcare "Leningradsky Regional Oncologic Dispensary" Saint Petersburg, Russia
View Trial Details

Related conditions